Mast cell tumors (MCTs) are common cutaneous neoplasms in dogs. As treatment recommendations and prognostic factors for MCTs continually change, this article aims to demystify the clinical approach to MCTs by reviewing indications for use of the MCT prognostic panel, the clinical relevance of regional lymph node metastasis, and various local and systemic therapies.